Benefits of an Integrated Approach to Gene Therapy Development and Manufacturing jpversion
Benefits of an Integrated Approach to Gene Therapy Development and Manufacturing jpversion
「グローバルCDMOの戦略的な活用法」 遺伝子治療用ウイルスベクターの商業化には、規制遵守、設計、仕様、サプライチェーン戦略の慎重な検討が必要です。

Added Date:

2023-10-15

Filters:

Filter Category Filter Values
Specialty
  • End-to-end
Language
  • Japanese
Capability
  • Messenger Ribonucleic Acid (mRNA)
Asset Type
  • Webinar on-demand
Country
  • Japan
Region
  • Asia Pacific (APAC)
Buying Stage
  • Middle
Content Category
  • Collateral
Market Category
  • Advanced therapy

Country Availability:


()

Gated Form:

None Set